about
DNA-binding specificities of human transcription factorsImpact of cytosine methylation on DNA binding specificities of human transcription factors.Mice deficient of Myc super-enhancer region reveal differential control mechanism between normal and pathological growth.Multiplexed massively parallel SELEX for characterization of human transcription factor binding specificitiesGenome-wide analysis of ETS-family DNA-binding in vitro and in vivoMED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas.ERBB3-rs2292239 as primary type 1 diabetes association locus among non-HLA genes in ChineseCharacterization of the colorectal cancer-associated enhancer MYC-335 at 8q24: the role of rs67491583A Scalable Epitope Tagging Approach for High Throughput ChIP-Seq Analysis.Transcription factor binding in human cells occurs in dense clusters formed around cohesin anchor sites.The non-coding variant rs1800734 enhances DCLK3 expression through long-range interaction and promotes colorectal cancer progressionA prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding.Histone H3 lysine 4 monomethylation modulates long-range chromatin interactions at enhancers.The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling.Mice lacking a Myc enhancer that includes human SNP rs6983267 are resistant to intestinal tumors.Pancreatic islet chromatin accessibility and conformation reveals distal enhancer networks of type 2 diabetes riskAn array of 60,000 antibodies for proteome-scale antibody generation and target discoverySuper-enhancers in transcriptional regulation and genome organization
P50
Q28854562-C7DF773D-122B-4153-9171-D8A274DF6B05Q31814782-A87FDBCE-34BD-4B62-A682-B083B293DF0CQ33769766-1079CA51-2AA8-42EA-9599-ECA2E3121544Q33881396-FB6C9D7D-04A9-44A8-8066-6C66922C807FQ34000149-988B3D16-A4F1-4887-8FE1-81847A6E5BDEQ34210977-B88ABADE-59F2-4F0F-B0A8-747D1498851DQ37005340-98BCB782-929C-47E5-8D90-EF24388DF669Q37163691-88F570B0-A40A-44CA-9609-AD686DFCFAC6Q38715835-8EC24850-1775-431F-BB2E-FD6687C573C1Q39109246-998C14C6-DB8E-4048-BDB1-24F9E9595AA3Q40337066-CC04DB56-8113-4500-A2ED-3B84F3E3F487Q46000370-CFC54D00-F319-40FB-A657-FC38A8C31E79Q50126824-590561A4-0D29-426A-A225-1C2BA8EB1501Q51565310-042A3AE1-5B9A-48BD-ABF4-A2A5A28E7A8BQ54324466-459BA1EC-273B-48D3-8F61-3CCD29BB08CEQ64064136-E3500603-2768-476B-8F40-AFD84F3B9758Q90485061-318C4B91-87F4-468D-94C2-592963695172Q91277025-B4331D86-2D63-4F74-877A-8AE9F8A318C9
P50
description
onderzoeker
@nl
researcher ORCID: 0000-0002-1267-2870
@en
name
Jian Yan
@ast
Jian Yan
@en
Jian Yan
@es
Jian Yan
@nl
Jian Yan
@sl
type
label
Jian Yan
@ast
Jian Yan
@en
Jian Yan
@es
Jian Yan
@nl
Jian Yan
@sl
prefLabel
Jian Yan
@ast
Jian Yan
@en
Jian Yan
@es
Jian Yan
@nl
Jian Yan
@sl
P106
P31
P496
0000-0002-1267-2870